🇵🇹 Portugal news, in English, every morning. Free. Subscribe
Sign in Subscribe

news

Breaking news and developing stories from across Portugal.
Council of Ministers Reworks the IVA Liquidation Regime on Combustíveis to Choke Out Fuel-Sector Fraud — Leitão Amaro Backs the CIVA Adjustment as the Same 11 June Vote Wraps an SME Capital-Markets Simplification Package

Council of Ministers Reworks the IVA Liquidation Regime on Combustíveis to Choke Out Fuel-Sector Fraud — Leitão Amaro Backs the CIVA Adjustment as the Same 11 June Vote Wraps an SME Capital-Markets Simplification Package

The Council of Ministers approved a CIVA rework on 11 June 2026 that shifts the VAT liquidation moment on combustíveis upstream to the entrepôt aduaneiro entry gateway — closing the missing-trader gap, alongside a paired SME capital-markets simplification package.
The Portugal Brief
Lisbon Calls For an EU Spending-Safeguard Carve-Out on Power-Bill Support — Miranda Sarmento Pitches the Energy-Crisis Exception to the Eurogroup as Portugal Ranks Fifth on the Energy-Support Share-of-GDP Tape

Lisbon Calls For an EU Spending-Safeguard Carve-Out on Power-Bill Support — Miranda Sarmento Pitches the Energy-Crisis Exception to the Eurogroup as Portugal Ranks Fifth on the Energy-Support Share-of-GDP Tape

Joaquim Miranda Sarmento told the 11 June Eurogroup in Luxembourg that the European Commission must create an energy-crisis escape clause modelled on the defense-spending carve-out — Portugal ranks fifth in the EU on energy-support share of GDP and is asking for the same fiscal-rules treatment.
The Portugal Brief
Fundo Ambiental Reignites the Incentivo Veículos Elétricos with a €10 Million Envelope — €4,000 Per Household BEV, €5,000 for IPSS, 278 Charging-Station Awards and 1,375 Target Subsidies Through 27 July

Fundo Ambiental Reignites the Incentivo Veículos Elétricos with a €10 Million Envelope — €4,000 Per Household BEV, €5,000 for IPSS, 278 Charging-Station Awards and 1,375 Target Subsidies Through 27 July

Portugal's Fundo Ambiental reopened the 2026 Incentivo Aquisição Veículos Elétricos on 11 June 16:30 with a €10 million envelope: €4,000 per household BEV (≤€38,500), €5,000 for IPSS, 278 charging-station awards and 1,375 target subsidies through 27 July under Aviso 06/2025.
The Portugal Brief
Continental Mabor Adds 215 Operationals at Famalicão to Hit a 3,200-Worker Record — Lousado Tyre Plant Marks 80 Years of Production and 36 Years Inside Continental as a FORAVE Skills Memorandum Lands

Continental Mabor Adds 215 Operationals at Famalicão to Hit a 3,200-Worker Record — Lousado Tyre Plant Marks 80 Years of Production and 36 Years Inside Continental as a FORAVE Skills Memorandum Lands

Continental Mabor confirmed 215 new Lousado hires in the first half of 2026 — workforce climbs to 3,200, an all-time Famalicão record — as Pedro Carreira marks 80 years of tyre production and 36 years inside Continental AG and signs a FORAVE skills memorandum with the Câmara Municipal.
The Portugal Brief
Portugal M&A Tape Skids Through Jan-April 2026 With Deal Count Down 32% and Value Down 28% on TTR Data's Read — €1.3 Billion Across 141 Operations as Tech and Real Estate Tie at 21 Each and Spanish Buyers Lead Cross-Border Inflow

Portugal M&A Tape Skids Through Jan-April 2026 With Deal Count Down 32% and Value Down 28% on TTR Data's Read — €1.3 Billion Across 141 Operations as Tech and Real Estate Tie at 21 Each and Spanish Buyers Lead Cross-Border Inflow

The Portuguese mergers-and-acquisitions tape continued the sharp deceleration that took hold across the first quarter, with TTR Data's Jan-April 2026 reading (released 13 May and updated in the late-May / early-June Iberian-desk follow-ups) putting...
The Portugal Brief
Bial Shelves the BIA 28-6156 Parkinson Phase 2 Trial After the Trofa Pharma Reads No Efficacy Signal at the Primary Endpoint — Five-Year Disease-Modification Programme Folded as the Compound Misses Its Placebo Comparator

Bial Shelves the BIA 28-6156 Parkinson Phase 2 Trial After the Trofa Pharma Reads No Efficacy Signal at the Primary Endpoint — Five-Year Disease-Modification Programme Folded as the Compound Misses Its Placebo Comparator

Bial-Portela & C. (Bial), the Trofa-based family-owned pharmaceutical company that remains Portugal's largest independent drug developer, confirmed on Monday 9 June 2026 that it has discontinued the clinical development of BIA 28-6156 , the...
The Portugal Brief